For InvestorsAntares Pharma: Making Medicines Feel Better

Press Release Archive

This section contains information and press releases about us. This information should be considered accurate only as of the date prepared. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Antares Pharma, Inc. is not obligated to update the press releases and information contained in this section of the Company’s website.

2014

06 Jan 2014
Antares Pharma to Present at the 32nd Annual JP Morgan Healthcare Conference

15 Jan 2014
Antares Pharma Announces Availability of OTREXUP (METHOTREXATE) Injection for Subcutaneous use to Treat RA and Psoriasis in Adults and Polyarticular Idiopathic Arthritis in Children

19 Feb 2014
Antares Pharma to Participate in the 2014 RBC Capital Markets' Global Healthcare Conference

20 Feb 2014
Antares Pharma Announces Positive Results From the Vibex Quickshot Pharmacokinetic Study in Testosterone Deficient Men

06 Mar 2014
Antares Pharma to Host Fourth Quarter 2013 Operating and Financial Results Conference Call

10 Mar 2014
Antares Pharma Announces LEO Pharma's Launch of OTREXUP (Methotrexate) Injection to Dermatologists for Adults with Psoriasis

12 Mar 2014
Antares Pharma Receives Second Milestone Payment from LEO Pharma in OTREXUP Collaboration

13 Mar 2014
Antares Pharma Reports Fourth Quarter and Full Year 2013 Operating and Financial Results

16 Apr 2014
Antares Pharma Announces Additional Patent Coverage for OTREXUP

17 Apr 2014
Drug-Exposure Limitations of Oral Methotrexate at Doses Greater than or Equal to 15 MG May be overcome with subcutaneous administration

24 Apr 2014
Antares Pharma to Present at the Deutsche Bank Securities Inc. 39th Annual Healthcare Conference

06 May 2014
Antares Pharma Announces Update to Quickshot Testosterone Program

09 May 2014
Antares Pharma Reports First Quarter 2014 Operating and Financial Results

07 May 2014
Antares Pharma to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference

20 May 2014
Antares Pharma Announces the Publication of Three Abstracts at the 2014 European League Against Rheumatism Annual Congress

22 May 2014
Antares Pharma Appoints Jennifer Evans Stacey ESQ., Senior Vice President , General Counsel, Human Resources and Secretary

28 May 2014
Antares Pharma to Present at the Jefferies 2014 Global Healthcare Conference

24 Jun 2014
Antares Pharma Announces Change in Senior Leadership

25 Jun 2014
Rapid Restoration and Consistent Maintenance of Steady Blood Levels Achieved With Once-Weekly Subcutaneous Administration of Testosterone Delivered With a Novel Auto Injector

22 Jul 2014
Antares Pharma Annouces First Patient Dosed In Phase 3 QuickShot® Study Evaluating Testosterone-Deficient Adult Males

31 Jul 2014
Antares Pharma to Host Second Quarter 2014 Operating and Financial Results Conference Call

03 Sep 2014
Antares Pharma to Present at the Morgan Stanley Healthcare Conference

15 Sep 2014
Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer

05 Aug 2014
Antares Pharma Reports Second Quarter 2014 Operating and Financial Results

30 Oct 2014
Antares Pharma to Host Third Quarter 2014 Operating and Financial Results Conference Call

03 Nov 2014
Antares Pharma Announces Last Patient Enrolled in Phase 3 Quickshot Study Evaluating Testosterone-Deficient Adult Males

06 Nov 2014
Antares Pharma Reports Third Quarter 2014 Operating and Financial Results

18 Nov 2014
Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer

25 Nov 2014
Antares Pharma to Present at the 26th Annual Piper Jaffray Healthcare Conference

03 Dec 2014
Antares Pharma to Present at the 25th Annual Oppenheimer Healthcare Conference

For Investors

Press Archive

  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013


  • Sign up for breaking news on ATRS

    * indicates required